ethics

The California Institute of Regenerative Medicine, a state-run agency that funds stem cell research, is considering funding research on human embryos using a gene-editing technology known as CRISPR-Cas9. This could potentially allow for cures to be discovered for devastating inherited diseases.
A Phase I clinical trial in France resulted in one death and hospitalization of five other study participants, three of which have irreversible brain damage. Prosecutors there are beginning a manslaughter investigation which will threaten the stability of any future drug trial.